Abstract 10467: Efficacy and Safety of Sotatercept in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease despite advances in targeted therapies. Sotatercept, a first-in-class activin receptor type IIA ligand trap, targets pulmonary vascular remodeling and may provide a disease-modifying treatment approach. Research ques...